AstraZeneca Files Litigation Against Salubris About Ticagrelor Tablets--the 350th Issue-China Intellectual Property

AstraZeneca Files Litigation Against Salubris About Ticagrelor Tablets--the 350th Issue

Hot Topics

·AstraZeneca Files the Litigation Against Salubris About Ticagrelor Tablets

On Jan 16, 2018, AstraZeneca officially filed a litigation to Beijing IP Court against the patent invalid announcement More

·Copyright Protection Center of China National Academy of Painting Establishes

With the prosperity of art creation and development of artwork trade, it arouse wide attention... More

·The 8th China IP Annual Forum to Convoke on Jan 27-28

Themed as “Transformation – Reinstalling the IP Value of Enterprises”, The 8th China IP International... More

News in Brief

· Shanghai Pudong New Area People’s Court Intensively Sentences 6 IP Criminal Cases

· Sony/ATV and Facebook Sign Ground-Breaking Copyright Licensing Agreement

· International Trademark Association Elects Tish Berard Of Hearts On Fire As 2018 President

· EPO Finishes Internal Retrenchment to Improve Patent Licensing Quality

· Chile Starts to Provide ISA and IPEA Service in English Since January 1

· Youku Sues Baidu and Other Companies for Infringement of Showing Wolf Warrior II

· SIPO Commissioner Meets with WIPO DDG

· China’s Valid Invention Patent Inventory Top 3 in the World in 2017

·SPC Head: Special Supervisors to Play Enhanced Role

· First Global Cross-Border E-Commerce Conference Will Be Held in Beijing in Early February

China IP Articles

·Challenges and Suggestions on the Application and Protection of IP in the Era of AI
Issue 82, By Wu Xiaolei, Senior Manager of Patent Office, Baidu,[Comprehensive Reports]

It’s not difficult to determine that the era of AI has come. So, perhaps we need to ask: what is AI... More

·Views and Comments on Protection for AI Creations in Copyright Law
Issue 82, By Ke Xuning, Judge at IP Tribunal of Nanjing Municipal Intermediate People’s Court,[Comprehensive Reports]

Due to the technological development, artificial intelligence (AI) has, under the joint action of technologies... More

Forward Subscription January 19th, 2018

Our Products

Homepage Cancel Subscription Contact China IP

This Publication is subject to the ownership of China IP. Neither the publication nor any portion hereof may be reprinted, sold or redistributed without written consent of China IP